Anika Therapeutics (ANIK) Stock Price, Quote & News

Company Profile

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 457 9000

Fax: 781 305 9720

Website: www.anika.com

Address:

32 Wiggins Avenue, Bedford, United States

US_Bull Aug. 16 at 8:32 PM

$ANIK I will quietly keep accumulating while this company is still under the radar of many. I see them hopefully turning the corner by Q2 next year.

0 · Reply

US_Bull Aug. 13 at 3:29 PM

$ANIK Got more at 9,06$ total 3,442 shares that is good enough for me on a 8,6$ average.

1 · Reply

US_Bull Aug. 13 at 3:20 PM

$ANIK 70% of daily average shares traded already bottom is in. Time to go long with the tutes.

0 · Reply

US_Bull Aug. 13 at 12:33 PM

$ANIK "ExodusPoint Capital Management LP bought a new position in Anika Therapeutics in the fourth quarter worth approximately $264,000. Finally, Wells Fargo & Company MN grew its stake in Anika Therapeutics by 31.1% in the fourth quarter. Wells Fargo & Company MN now owns 7,421 shares of the biotechnology company's stock worth $122,000 after purchasing an additional 1,759 shares in the last quarter. 91.53% of the stock is owned by hedge funds and other institutional investors." Cheryl time to deliver or sell the company to a bigger medico company that can actually grow revenues and sales.

0 · Reply

US_Bull Aug. 13 at 12:33 PM

$ANIK "Other institutional investors have also modified their holdings of the company. American Century Companies Inc. grew its stake in Anika Therapeutics by 9.3% in the fourth quarter. American Century Companies Inc. now owns 29,891 shares of the biotechnology company's stock worth $492,000 after purchasing an additional 2,553 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Anika Therapeutics by 431.9% in the fourth quarter. JPMorgan Chase & Co. now owns 82,491 shares of the biotechnology company's stock worth $1,358,000 after purchasing an additional 66,982 shares in the last quarter. Wellington Management Group LLP grew its stake in Anika Therapeutics by 3.7% in the fourth quarter. Wellington Management Group LLP now owns 39,785 shares of the biotechnology company's stock worth $655,000 after purchasing an additional 1,407 shares in the last quarter.

0 · Reply

US_Bull Aug. 12 at 8:27 PM

$ANIK Also volume is 33% above daily average so buying has started.

0 · Reply

US_Bull Aug. 12 at 8:25 PM

$ANIK This is the bottom market cap is way below revenues just purely on technicals stock is way oversold.

0 · Reply

US_Bull Aug. 12 at 6:17 PM

$ANIK Time to get a new CEO or sell the company.

0 · Reply

AnalyticaInvestor Aug. 8 at 11:02 AM

$ACHV $SUNS $BDTX $ANIK $WHF Small-Cap Movers: $ACHV: biotech name in focus after recent trial updates $SUNS: steady BDC yield play with income appeal $BDTX: precision oncology story gaining attention $ANIK: med-tech firm riding joint-health product demand $WHF: dividend-focused BDC with insider interest https://analyticainvestor.beehiiv.com/p/insider-buying-spurs-biotech-reit-momentum-52f3bd24083ac913

0 · Reply

YouOnlyLiveTwice Aug. 7 at 4:43 PM

$ANIK good call

1 · Reply

Anika Therapeutics: Undervalued HA Platform With 2027 Catalysts

Jul 30, 2025, 10:52 AM EDT - 20 days ago

Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 7:05 AM EDT - 21 days ago

Anika Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 7:00 AM EDT - 21 days ago

Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update

Jul 16, 2025, 4:01 PM EDT - 4 weeks ago

Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025

Jul 3, 2025, 5:00 PM EDT - 6 weeks ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 9, 2025, 11:51 AM EDT - 3 months ago

Anika Therapeutics, Inc. (ANIK) Q1 2025 Earnings Call Transcript

May 9, 2025, 7:05 AM EDT - 3 months ago

Anika Reports First Quarter 2025 Financial Results

May 7, 2025, 4:01 PM EDT - 3 months ago

Anika to Participate in the Sidoti Virtual Investor Conference

Apr 25, 2025, 9:00 AM EDT - 4 months ago

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

Mar 12, 2025, 5:55 PM EDT - 5 months ago

Anika Therapeutics, Inc. (ANIK) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 5 months ago

Anika Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 7, 2025, 6:00 AM EST - 5 months ago

Anika Completes Divestiture of Parcus Medical

Feb 26, 2025, 8:00 AM EST - 6 months ago

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

Feb 25, 2025, 8:00 AM EST - 6 months ago

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

Dec 23, 2024, 4:01 PM EST - 8 months ago

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Nov 22, 2024, 4:16 PM EST - 9 months ago

Anika To Participate in December 2024 Investor Conferences

Nov 2, 2024, 9:41 PM EDT - 10 months ago

Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 11:00 AM EDT - 10 months ago

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Oct 31, 2024, 7:05 AM EDT - 10 months ago

Anika Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 7:00 AM EDT - 10 months ago

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Oct 17, 2024, 4:01 PM EDT - 10 months ago

Anika Announces Third Quarter 2024 Results Conference Call Date

Aug 11, 2024, 1:49 AM EDT - 1 year ago

Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Anika Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 11, 2024, 8:30 AM EDT - 1 year ago

Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs

Jul 1, 2024, 10:35 AM EDT - 1 year ago

Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research

May 28, 2024, 4:05 PM EDT - 1 year ago

Anika Enters into Cooperation Agreement with Caligan Partners

May 8, 2024, 11:36 PM EDT - 1 year ago

Anika Therapeutics, Inc. (ANIK) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:08 PM EDT - 1 year ago

Anika Announces CFO Transition

May 8, 2024, 4:05 PM EDT - 1 year ago

Anika Reports First Quarter 2024 Financial Results

Apr 18, 2024, 4:01 PM EDT - 1 year ago

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Apr 2, 2024, 8:00 AM EDT - 1 year ago

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Mar 13, 2024, 7:17 PM EDT - 1 year ago

Anika Therapeutics, Inc. (ANIK) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:05 PM EDT - 1 year ago

Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Feb 27, 2024, 4:01 PM EST - 1 year ago

Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

Feb 13, 2024, 9:00 AM EST - 1 year ago

Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting

Nov 28, 2023, 9:00 AM EST - 1 year ago

Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

Nov 7, 2023, 4:05 PM EST - 1 year ago

Anika to Participate in Upcoming Investor Conferences

Nov 3, 2023, 4:34 PM EDT - 1 year ago

Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

Sep 19, 2023, 9:00 AM EDT - 2 years ago

Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting

Sep 12, 2023, 9:00 AM EDT - 2 years ago

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

US_Bull Aug. 16 at 8:32 PM

$ANIK I will quietly keep accumulating while this company is still under the radar of many. I see them hopefully turning the corner by Q2 next year.

0 · Reply

US_Bull Aug. 13 at 3:29 PM

$ANIK Got more at 9,06$ total 3,442 shares that is good enough for me on a 8,6$ average.

1 · Reply

US_Bull Aug. 13 at 3:20 PM

$ANIK 70% of daily average shares traded already bottom is in. Time to go long with the tutes.

0 · Reply

US_Bull Aug. 13 at 12:33 PM

0 · Reply

US_Bull Aug. 13 at 12:33 PM

0 · Reply

US_Bull Aug. 12 at 8:27 PM

$ANIK Also volume is 33% above daily average so buying has started.

0 · Reply

US_Bull Aug. 12 at 8:25 PM

$ANIK This is the bottom market cap is way below revenues just purely on technicals stock is way oversold.

0 · Reply

US_Bull Aug. 12 at 6:17 PM

$ANIK Time to get a new CEO or sell the company.

0 · Reply

AnalyticaInvestor Aug. 8 at 11:02 AM

0 · Reply

YouOnlyLiveTwice Aug. 7 at 4:43 PM

$ANIK good call

1 · Reply

YouOnlyLiveTwice Aug. 5 at 2:00 PM

$ANIK This firm definitely got taken for a ride right down the drain

1 · Reply

richardred Aug. 1 at 7:58 PM

$ANIK double the average volume today. Maybe the company buying some shares today?

1 · Reply

anachartanalyst Jul. 31 at 12:02 PM

$ANIK https://anachart.com/wp-content/uploads/ana_temp/1753963314_soc-img.jpg

0 · Reply

JarvisFlow Jul. 31 at 12:00 PM

Barrington Research updates rating for Anika Therapeutics ( $ANIK ) to Outperform, target set at 19 → 15.

0 · Reply

YouOnlyLiveTwice Jul. 30 at 10:03 PM

$ANIK CEO “We delivered a meaningful quarter” I mean the carnage since she became CEO. Single handily destroyed a company that was built by Sherwood and Sylvia What a disgrace ..she needs to be fired and the entire BOD needs to be fired for allowing her to destroy this company

0 · Reply

YouOnlyLiveTwice Jul. 30 at 9:56 PM

$ANIK BK soon

2 · Reply

Messerschmittbf109 Jul. 30 at 7:57 PM

$ANIK thanks ..bad

0 · Reply

breaktime Jul. 30 at 4:25 PM

$ANIK starting to gain a little ground... Based on the latest available information, BlackRock, Inc. owns 6.8% of Anika Therapeutics, Inc. (ANIK) stock

0 · Reply

richardred Jul. 30 at 3:15 PM

$ANIK Ok I’m glad I waited. Bought some today near the low. IMO It’s golden parachute time.

0 · Reply

breaktime Jul. 30 at 2:35 PM

$ANIK added 8.30 now sitting with more than I wanted at 8.80

0 · Reply

Livinglifewithlivingston Jul. 30 at 2:28 PM

$ANIK I’m in

0 · Reply

breaktime Jul. 30 at 2:04 PM

$ANIK way early on the entry, maybe I will be paying for my own lunch and theirs

0 · Reply

Market Cap	125.29M
Revenue (ttm)	119.91M
Net Income (ttm)	-56.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47.03%
Debt to Equity Ratio	0.00

Volume	75,100
Avg Vol	122,038
Day's Range	N/A - N/A
Shares Out	14.42M
Stochastic %K	50%
Beta	0.64
Analysts	Strong Sell
Price Target	$18.33